I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 16 studies | 33% ± 12% | |
| CD16-positive, CD56-dim natural killer cell, human | 8 studies | 17% ± 2% | |
| conventional dendritic cell | 7 studies | 30% ± 12% | |
| natural killer cell | 7 studies | 21% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 17% ± 2% | |
| classical monocyte | 5 studies | 20% ± 5% | |
| macrophage | 5 studies | 20% ± 4% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 16% ± 0% | |
| hematopoietic precursor cell | 3 studies | 22% ± 3% | |
| mature NK T cell | 3 studies | 16% ± 1% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 20% ± 1% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
| common myeloid progenitor | 3 studies | 23% ± 7% | |
| endothelial cell | 3 studies | 21% ± 3% | |
| ciliated cell | 3 studies | 20% ± 3% | |
| dendritic cell | 3 studies | 43% ± 11% |
